Article

NEDD9 Overexpression Causes Hyperproliferation of Luminal Cells and Cooperates with HER2 Oncogene in Tumor Initiation: A Novel Prognostic Marker in Breast Cancer

2023-01-03

Abstract excerpt

The HER2 overexpression occurs in 10–20% of breast cancer patients. HER2+ tumors are characterized by increase in Ki67, early relapse and increased metastasis. There is little known about factors influencing early stages of HER2- tumorigenesis and diagnostic markers. Previously, it was shown that deletion of NEDD9 in mouse models of HER2 cancer interferes with tumor growth, but the role of NEDD9 upregulation...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 654909f0-0905-533f-92c6-281560f5f200
DOI: 10.20944/preprints202301.0005.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

NEDD9 Overexpression Causes Hyperproliferation of Luminal Cells and Cooperates with HER2 Oncogene in Tumor Initiation: A Novel Prognostic Marker in Breast CancerDOI 10.20944/preprints202301.0005.v1Read

NEDD9 is transcriptionally regulated by HDAC4 and promotes breast cancer metastasis and macrophage M2 polarization via the FAK/NF-κB signaling pathwaySemantic proximity Read

Neddylation of HER2 Inhibits its Protein Degradation and promotes Breast Cancer ProgressionSemantic proximity Read

Expression profiling of in vivo ductal carcinoma in situ progression models identified B cell lymphoma-9 as a molecular driver of breast cancer invasionSemantic proximity Read

Loss of Dickkopf 3 Promotes the Tumorigenesis of Basal Breast CancerSemantic proximity Read

The chromatin remodeler DEK promotes proliferation of mammary epithelium and is associated with H3K27me3 epigenetic modificationsSemantic proximity Read

Targeting NAE1-mediated protein hyper-NEDDylation halts cholangiocarcinogenesis and impacts on tumor-stroma crosstalk in experimental modelsSemantic proximity Read

Neddylation controls basal MKK7 kinase activity in breast cancer cells.Semantic proximity Read

Ecdysoneless Overexpression Drives Mammary Tumorigenesis through Upregulation of C-MYC and Glucose MetabolismSemantic proximity Read

DDB2: A Novel Regulator of NF-κB and Breast Tumor InvasionSemantic proximity Read

Identification of early molecular markers for breast cancerSemantic proximity Read

CDK19 is a Regulator of Triple-Negative Breast Cancer GrowthSemantic proximity Read

Homeobox D9 drives the malignant phenotypes and enhances the Programmed death ligand-1 expression in non-small cell lung cancer cells via binding to Angiopoietin-2 promoter.Semantic proximity Read